BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29043580)

  • 1. A Comprehensive Assessment of Accurate Lymph Node Staging and Preoperative Detection in Resected Pancreatic Cancer.
    Masuda T; Dann AM; Elliott IA; Baba H; Kim S; Sedarat A; Muthusamy VR; Girgis MD; Joe Hines O; Reber HA; Donahue TR
    J Gastrointest Surg; 2018 Feb; 22(2):295-302. PubMed ID: 29043580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival.
    Morales-Oyarvide V; Rubinson DA; Dunne RF; Kozak MM; Bui JL; Yuan C; Qian ZR; Babic A; Da Silva A; Nowak JA; Khalaf N; Brais LK; Welch MW; Zellers CL; Ng K; Chang DT; Miksad RA; Bullock AJ; Tseng JF; Swanson RS; Clancy TE; Linehan DC; Findeis-Hosey JJ; Doyle LA; Hornick JL; Ogino S; Fuchs CS; Hezel AF; Koong AC; Wolpin BM
    Br J Cancer; 2017 Dec; 117(12):1874-1882. PubMed ID: 28982112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with node-negative disease.
    Williams JL; Nguyen AH; Rochefort M; Muthusamy VR; Wainberg ZA; Dawson DW; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
    J Surg Oncol; 2015 Sep; 112(4):396-402. PubMed ID: 26303811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Single-Institution Validation Study of Lymph Node Staging By the AJCC 8th Edition for Patients with Pancreatic Head Cancer: A Proposal to Subdivide the N2 Category.
    Asano D; Nara S; Kishi Y; Esaki M; Hiraoka N; Tanabe M; Shimada K
    Ann Surg Oncol; 2019 Jul; 26(7):2112-2120. PubMed ID: 31037440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma.
    Huebner M; Kendrick M; Reid-Lombardo KM; Que F; Therneau T; Qin R; Donohue J; Nagorney D; Farnell M; Sarr M
    J Gastrointest Surg; 2012 May; 16(5):920-6. PubMed ID: 22421988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma.
    Shin DW; Lee JC; Kim J; Woo SM; Lee WJ; Han SS; Park SJ; Choi KS; Cha HS; Yoon YS; Han HS; Hong EK; Hwang JH
    Eur J Surg Oncol; 2019 Nov; 45(11):2159-2165. PubMed ID: 31202572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma.
    Malleo G; Maggino L; Nobile S; Casciani F; Cacciatori N; Paiella S; Luchini C; Rusev B; Capelli P; Marchegiani G; Bassi C; Salvia R
    Eur J Surg Oncol; 2020 Sep; 46(9):1734-1741. PubMed ID: 32327367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic ductal adenocarcinoma (PDAC) regional nodal disease at standard lymphadenectomy: is MRI accurate for identifying node-positive patients?
    Adham S; Ferri M; Lee SY; Larocque N; Alwahbi OA; Ruo L; van der Pol CB
    Eur Radiol; 2023 Sep; 33(9):5976-5983. PubMed ID: 37004569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy.
    Lee D; Yoo S; You D; Hong B; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY; Jeong IG
    Urol Oncol; 2017 Apr; 35(4):151.e1-151.e7. PubMed ID: 28139370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Number of Examined Lymph Nodes and Nodal Status Assessment in Distal Pancreatectomy for Body/Tail Ductal Adenocarcinoma.
    Malleo G; Maggino L; Ferrone CR; Marchegiani G; Mino-Kenudson M; Capelli P; Rusev B; Lillemoe KD; Bassi C; Fernàndez-Del Castillo C; Salvia R
    Ann Surg; 2019 Dec; 270(6):1138-1146. PubMed ID: 29672406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer.
    Imai H; Doi R; Kanazawa H; Kamo N; Koizumi M; Masui T; Iwanaga Y; Kawaguchi Y; Takada Y; Isoda H; Uemoto S
    Int J Clin Oncol; 2010 Jun; 15(3):294-300. PubMed ID: 20232101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatment sequencing.
    Oppliger FA; Prakash LR; Newhook TE; Chiang YJ; Ikoma N; Maxwell JE; Kim MP; Vauthey JN; Lee JE; Katz MH; Tzeng CD
    Surg Oncol; 2022 Mar; 40():101673. PubMed ID: 34894620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma of the pancreas: Does prognosis depend on mode of lymph node invasion?
    Buc E; Couvelard A; Kwiatkowski F; Dokmak S; Ruszniewski P; Hammel P; Belghiti J; Sauvanet A
    Eur J Surg Oncol; 2014 Nov; 40(11):1578-85. PubMed ID: 24923739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathomorphological features of metastatic lymph nodes as predictors of postoperative prognosis in pancreatic cancer.
    Hoshikawa M; Ogata S; Nishikawa M; Kimura A; Einama T; Noro T; Aosasa S; Hase K; Tsujimoto H; Ueno H; Yamamoto J
    Medicine (Baltimore); 2019 Feb; 98(5):e14369. PubMed ID: 30702628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic Cancer.
    Honselmann KC; Pergolini I; Castillo CF; Deshpande V; Ting D; Taylor MS; Bolm L; Qadan M; Wellner U; Sandini M; Bausch D; Warshaw AL; Lillemoe KD; Keck T; Ferrone CR
    Ann Surg; 2020 Aug; 272(2):357-365. PubMed ID: 32675550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.
    Riediger H; Keck T; Wellner U; zur Hausen A; Adam U; Hopt UT; Makowiec F
    J Gastrointest Surg; 2009 Jul; 13(7):1337-44. PubMed ID: 19418101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Endosonographic Mediastinal Lymph Node Staging in Positron Emission Tomography and Computed Tomography Node-Negative Non-Small-Cell Lung Cancer in High-Risk Patients.
    Hegde P; Molina JC; Thivierge-Southidara M; Jain RV; Gowda A; Ferraro P; Liberman M
    Semin Thorac Cardiovasc Surg; 2020; 32(1):162-168. PubMed ID: 31325576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can standardized pathology examination increase the lymph node yield following laparoscopic distal pancreatectomy for ductal adenocarcinoma?
    Sahakyan MA; Haugvik SP; Røsok BI; Kazaryan AM; Ignjatovic D; Buanes T; Labori KJ; Verbeke CS; Edwin B
    HPB (Oxford); 2018 Feb; 20(2):175-181. PubMed ID: 28943397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining a minimum number of examined lymph nodes improves the prognostic value of lymphadenectomy in pancreas ductal adenocarcinoma.
    Pu N; Gao S; Beckman R; Ding D; Wright M; Chen Z; Zhu Y; Hu H; Yin L; Beckman M; Thompson E; Hruban RH; Cameron JL; Gage MM; Lafaro KJ; Burns WR; Wolfgang CL; He J; Yu J; Burkhart RA
    HPB (Oxford); 2021 Apr; 23(4):575-586. PubMed ID: 32900612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the number of positive lymph nodes and lymph node ratio on prognosis of patients after resection of pancreatic adenocarcinoma.
    Liu ZQ; Xiao ZW; Luo GP; Liu L; Liu C; Xu J; Long J; Ni QX; Yu XJ
    Hepatobiliary Pancreat Dis Int; 2014 Dec; 13(6):634-41. PubMed ID: 25475867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.